The Restoring Invisible and Abandoned Trials (RIAT) proposal, backed by the British Medical Journal and PLoS ONE last week, calls for the “responsible publication and republication of abandoned studies” by the studies’ original authors within one year, or for all publicly available data for such trials to then be considered publishable by others.
Of Further Interest:
PLOS ONE welcomes RIAT (Restoring Invisible and Abandoned Trials) Initiative (PLoS ONE)
Restoring invisible and abandoned trials: a call for people to publish the findings (BMJ)
Restoring the integrity of the clinical trial evidence base (BMJ)
Experts: Publish ‘Invisible’ and ‘Abandoned’ Clinical Trials (Medscape)
Restoring Invisible and Abandoned Trials (RIAT) “to correct the scientific record” (DavidHealy.org)
It’s amazing that drug companies have been able to hide unfavorable drug trials from the public record; it is hard to imagine who’d oppose such a proposal (besides the drug companies).
Report comment
If they do so, will there be any drugs that out-perform placebo?
Duane
Report comment
To quote John Hoggart in another post, “Ah, placebo, my favorite drug of choice!” It’s not a direct quote but I think he probably wont’t mind a little poetic liscense on my part with his statement.
Report comment
Yes, I remember that!
Oh wow, that was funny!
Duane
Report comment
Reality check:
Whose got the muscle to ram this through?
And if it looks as if its actually Going to be implemented, how long will it be before Senator Foghorn guts it with a rider or amendment to it or some other bill calling it a Protect Intellectual Property Rights issue?
This is not going to fly. Drug Makers and their Street Vendors have the money and machinery in place to make sure it never gets out of the stocks.
Look at what Congress did when they got caught up to their eye teeth in Insider Trading shennanigans.
http://www.breitbart.com/Big-Government/2013/04/15/Congress-Guts-Key-STOCK-Act-Provision
Report comment